SCHEMBL30375994

SCHEMBL30375994

CCCCOc1ccc(S(=O)(=O)NCCN2CCC(c3c[nH]c4ccc(C)cc34)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.49
KCNH2 Q12809 1/20 0.49
HTR6 P50406 6/20 0.44
HTR1A P08908 6/20 0.44
SLC6A4 P31645 6/20 0.44
DRD2 P14416 5/20 0.44
HTR7 P34969 5/20 0.44
HTR2A P28223 3/20 0.44
SLC2A1 P11166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25759401 1.00 KCNA5 (0.49) KCNA5KCNH2HTR6HTR1ASLC6A4
SCHEMBL25758322 0.92 SLC6A4 (0.53) KCNA5KCNH2HTR6HTR1ASLC6A4
SCHEMBL30375406 0.92 SLC6A4 (0.53) KCNA5KCNH2HTR6HTR1ASLC6A4
SCHEMBL30376202 0.89 KCNA5 (0.61) KCNA5KCNH2SLC6A4DRD2HTR7
SCHEMBL25759383 0.89 KCNA5 (0.61) KCNA5KCNH2SLC6A4DRD2HTR7
SCHEMBL25759431 0.85 KCNA5 (0.60) KCNA5KCNH2SLC6A4DRD2HTR7
SCHEMBL30375766 0.85 KCNA5 (0.60) KCNA5KCNH2SLC6A4DRD2HTR7
SCHEMBL23648880 0.79 SLC2A1 (0.44) HTR6HTR1ASLC6A4DRD2HTR7
SCHEMBL13285873 0.76 HTR7 (0.56) KCNA5KCNH2HTR7
SCHEMBL25286043 0.76 ADRA1D (0.50) KCNH2SLC6A4DRD2HTR7HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157124-A Sulfonamide derivative and pharmaceutical composition for preventing or treating mental diseases containing the same as active ingredient 大邱庆北尖端医疗产业振兴财团 2023-05-23 CN claimed
CN-116157124-A Sulfonamide derivative and pharmaceutical composition for preventing or treating mental diseases containing the same as active ingredient 大邱庆北尖端医疗产业振兴财团 2023-05-23 CN disclosed
EP-4159718-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS Daegu-Gyeongbuk Medical Innovation Foundation (KR) 2023-04-05 EP disclosed